Literature DB >> 19800382

Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats.

Yousef Tizabi1, Sheketha R Hauser, Khandra Y Tyler, Bruk Getachew, Reza Madani, Yukti Sharma, Kebreten F Manaye.   

Abstract

The observed high incidence of smoking amongst depressed individuals has led to the hypothesis of 'self medication" with nicotine in some of these patients. The inbred Wistar-Kyoto (WKY) rats exhibit depressive-like characteristics as evidenced by exaggerated immobility in the forced swim test (FST). One aim of this study was to investigate whether nicotine may have an antidepressant-like effect in these animals. Moreover, because of human postmortem studies indicating a reduction of the hippocampus volume in depressed patients, it was of interest to determine whether such an anatomical anomaly may also be manifested in WKY rats and whether it would be affected by chronic nicotine treatment. Adult female WKY and their control Wistar rats were administered nicotine consecutively (0.2 mg/kg, i.p., once or twice daily for 14 days) and their activity in an open field, as well as their immobility in FST were assessed either 15 min or 18 h after the last injection. Another set of animals was treated twice daily with 0.2 mg/kg nicotine for 14 days and sacrificed on day 15 for stereological evaluation of the hippocampal volume. When tested 15 min after the last injection, once or twice daily nicotine exacerbated the immobility in the FST in WKY rats only. When tested 18 h after the last injection, only twice daily nicotine treatment resulted in less immobility in the FST in WKY rats. Open field locomotor activity was not affected by any nicotine regimen. WKY rats had significantly less hippocampal volume (approximately 20%) than Wistar rats which was not altered by nicotine. These findings further validate the use of WKY rats as an animal model of human depression and signify the importance of inherent genetic differences in final behavioral outcome of nicotine. Copyright 2009. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800382      PMCID: PMC2814982          DOI: 10.1016/j.pnpbp.2009.09.024

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  77 in total

1.  Depressive characteristics of FSL rats: involvement of central nicotinic receptors.

Authors:  Y Tizabi; A H Rezvani1; L T Russell; K Y Tyler; D H Overstreet
Journal:  Pharmacol Biochem Behav       Date:  2000-05       Impact factor: 3.533

2.  Common genetic risk of major depression and nicotine dependence: the contribution of antisocial traits in a United States veteran male twin cohort.

Authors:  Qiang Fu; Andrew C Heath; Kathleen K Bucholz; Michael J Lyons; Ming T Tsuang; William R True; Seth A Eisen
Journal:  Twin Res Hum Genet       Date:  2007-06       Impact factor: 1.587

Review 3.  Biological aspects of the link between smoking and depression.

Authors:  E Quattrocki; A Baird; D Yurgelun-Todd
Journal:  Harv Rev Psychiatry       Date:  2000-09       Impact factor: 3.732

4.  Nicotine blocks ethanol-induced apoptosis in primary cultures of rat cerebral cortical and cerebellar granule cells.

Authors:  Yousef Tizabi; Kebreten F Manaye; Robert E Taylor
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

5.  Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence.

Authors:  R C Kessler; K A McGonagle; M Swartz; D G Blazer; C B Nelson
Journal:  J Affect Disord       Date:  1993 Oct-Nov       Impact factor: 4.839

Review 6.  Nicotine and Parkinson's disease: implications for therapy.

Authors:  Maryka Quik; Kathryn O'Leary; Caroline M Tanner
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

7.  Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease.

Authors:  Anne N Thorndike; Susan Regan; Kathleen McKool; Richard C Pasternak; Susan Swartz; Nancy Torres-Finnerty; Nancy A Rigotti
Journal:  Arch Intern Med       Date:  2008-01-28

Review 8.  Monoamine dysfunction and the pathophysiology and treatment of depression.

Authors:  D S Charney
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

9.  Chronic neonatal nicotine exposure increases mRNA expression of neurotrophic factors in the postnatal rat hippocampus.

Authors:  Jong-Hyun Son; Ursula H Winzer-Serhan
Journal:  Brain Res       Date:  2009-05-03       Impact factor: 3.252

Review 10.  Desensitization of nicotinic acetylcholine receptors as a strategy for drug development.

Authors:  Jerry J Buccafusco; J Warren Beach; Alvin V Terry
Journal:  J Pharmacol Exp Ther       Date:  2008-11-20       Impact factor: 4.030

View more
  25 in total

1.  Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF.

Authors:  Sheketha R Hauser; Bruk Getachew; Robert E Taylor; Yousef Tizabi
Journal:  Pharmacol Biochem Behav       Date:  2011-09-10       Impact factor: 3.533

2.  Antidepressant-like effects of curcumin in WKY rat model of depression is associated with an increase in hippocampal BDNF.

Authors:  Laura L Hurley; Luli Akinfiresoye; Evaristus Nwulia; Atsushi Kamiya; Amol A Kulkarni; Yousef Tizabi
Journal:  Behav Brain Res       Date:  2012-11-08       Impact factor: 3.332

3.  Inducing a long-term potentiation in the dentate gyrus is sufficient to produce rapid antidepressant-like effects.

Authors:  A Kanzari; C Bourcier-Lucas; A Freyssin; D N Abrous; N Haddjeri; G Lucas
Journal:  Mol Psychiatry       Date:  2017-05-09       Impact factor: 15.992

Review 4.  Neuroinflammation, neurodegeneration, and depression.

Authors:  Laura L Hurley; Yousef Tizabi
Journal:  Neurotox Res       Date:  2012-08-16       Impact factor: 3.911

5.  Antidepressant effects of resveratrol in an animal model of depression.

Authors:  Laura L Hurley; Luli Akinfiresoye; Olubukola Kalejaiye; Yousef Tizabi
Journal:  Behav Brain Res       Date:  2014-04-06       Impact factor: 3.332

6.  Antidepressant effects of moxidectin, an antiparasitic drug, in a rat model of depression.

Authors:  Bruk Getachew; Yousef Tizabi
Journal:  Behav Brain Res       Date:  2019-09-09       Impact factor: 3.332

7.  Retinal Nerve Fiber Layer Thickness Measurement by Spectral-Domain Optical Coherence Tomography in Patients with Major Depressive Disorder.

Authors:  İpek Sönmez; Ferdi Köşger; Ümit Aykan
Journal:  Noro Psikiyatr Ars       Date:  2017-03       Impact factor: 1.339

Review 8.  Duality of Antidepressants and Neuroprotectants.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2015-11-27       Impact factor: 3.911

9.  Frontoparietal attentional network activation differs between smokers and nonsmokers during affective cognition.

Authors:  Brett Froeliger; Leslie A Modlin; Rachel V Kozink; Lihong Wang; Eric L Garland; Merideth A Addicott; F Joseph McClernon
Journal:  Psychiatry Res       Date:  2012-11-13       Impact factor: 3.222

10.  Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR.

Authors:  Luli Akinfiresoye; Yousef Tizabi
Journal:  Psychopharmacology (Berl)       Date:  2013-06-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.